Clearwater International advises Pharma Santé Développement on its debt restructuring and financing of Optipharm

Clearwater International has advised Pharma Santé Développement Groupe (PSD), an association for pharmacies on its debt restructuring and financing of pharmacy group, Optipharm.

Founded in 1998 and with over 1,000 members, Optipharm is an association for independent pharmacies that offer a range of benefits including a central purchasing system directly from laboratories, inventory services, training and support for pharmacists, and merchandising and layout stands for stores.

PSD is an integrated alliance of three sub-brands Pharma Santé Développement, NEP LA MARQUE and Pharmacade. With more than 1,300 pharmacy members and an accumulative turnover of €2.3bn, the group have a strong presence across France.

The group, headed by Philippe Besnard, brought Connect Pro, SofiPaca, Etoile Capital and Smalt Capital in 2018 with the ambition of becoming the major player for pharmacies.

This acquisition will enable PSD and Optipharm to become a leading pharmaceutical association with a combined membership of over 2,500 pharmacies.

  • Image of Pharma Santé Développement Company Logo
    raised debt to refinance its existing debt and finance the acquisition of
    Image of Optipharma Company Logo
    Debt Advisory
    View Back of Transaction
    Clearwater Advisers

    Advisor to PSD on its refinancing and the financing of Optipharma

    View more